GENE - CHEMICAL INTERACTIONS REPORT
Note: Use of the qualifier "multiple interactions" designates that the annotated interaction
is comprised of a complex set of reactions and/or regulatory events, possibly involving
additional chemicals and/or gene products.
Object Symbol | Qualifier | Evidence | With | Reference | Source | Notes | Original Reference(s) | Slc2a5 | affects expression | EXP | | 6480464 | CTD | Dexamethasone affects the expression of SLC2A5 mRNA | PMID:15102944 | Slc2a5 | increases expression | EXP | | 6480464 | CTD | Dexamethasone results in increased expression of SLC2A5 mRNA | PMID:20032058 | Slc2a5 | multiple interactions | EXP | | 6480464 | CTD | Dexamethasone promotes the reaction [Fructose results in increased activity of SLC2A5 protein]; Dexamethasone promotes the reaction [Fructose results in increased expression of SLC2A5 mRNA]; Mifepristone inhibits the reaction [Dexamethasone promotes the reaction [Fructose results in increased activity of SLC2A5 protein]]; Mifepristone inhibits the reaction [Dexamethasone promotes the reaction [Fructose results in increased expression of SLC2A5 mRNA]]; Testosterone inhibits the reaction [Dexamethasone results in increased expression of SLC2A5 mRNA] | PMID:18556366 PMID:20032058 | Slc2a5 | multiple interactions | ISO | SLC2A5 (Homo sapiens) | 6480464 | CTD | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of SLC2A5 mRNA | PMID:28628672 | |
Go Back to source page | Continue to Ontology report |